Rebound airway obstruction and responsiveness after cessation of terbutaline: Effects of budesonide

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 1, 1996, Pages 70-75

  De Jong, Jan W ^a   Van Der Mark, Thomas W ^a   Koëter, Gerard H ^a   Postma, Dirkje S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; METHACHOLINE; PLACEBO; TERBUTALINE;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

EID: 0030049327     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.1.8542165     Document Type: Article

References (27)

1. McFadden, E. R., Jr. 1991. Fatal and near-fatal asthma. N. Engl. J. Med. 324:409-411.
2. Spitzer, W. O., S. Suissa, P. Ernst, R. I. Horwitz, B. Habbick, D. Cockcroft, J. F. Boivin, M. McNutt, A. S. Buist, and A. S. Rebuck. 1992. The use of β-agonists and the risk of death and near death from asthma. N. Engl. J. Med. 326:501-506.
3. Ernst, P., B. Habbick, S. Suissa, B. Hemmelgarn, D. Cockcroft, A. S. Buist, R. I. Horwitz, M. McNutt, and W. O. Spitzer. 1993. Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am. Rev. Respir. Dis. 148:75-79.
4. Suissa, S., P. Ernst, J. F. Boivin, R. I. Horwitz, B. Habbick, D. Cockroft, L. Blais, M. McNutt, A. S. Buist, and W.O. Spitzer. 1994. A cohort analysis of excess mortality in asthma and the use of inhaled β-agonists. Am. J. Respir. Crit. Care Med. 149:604-610.
5. Sears, M. R., D. R. Taylor, C. G. Print, D. C. Lake, Q. Li, E. M. Flannery, D. M. Yates, M. K. Lucas, and C. P. Herbison. 1990. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336: 1391-1396.
6. Taylor, D. R., M. R. Sears, G. P. Herbison, E. M. Flannery, C. G. Print, D. C. Lake, D. M. Yates, M. K. Lucas, and Q. Li. 1993. Regular inhaled β agonist in asthma: effects on exacerbations and lung function. Thorax 48:134-138.
7. van Schayck, C. P., E. Dompeling, C. L. A. van Herwaarden, H. Folgering, A. L. M. Verbeek, H. J. M. van der Hoogen, and C. van Weel. 1991. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. B.M.J. 303:1426-1431.
8. Haahtela, T., M. Järvinen, T. Kava, K. Kiviranta, S. Koskinen, K. Lehtonen, K. Nikander, T. Persson, K. Reinikainen, O. Selroos, A. Sovijärvi, B. Steniuis-Aarniala, T. Svahn, R. Tammivaara, and L. A. Laitinen. 1991. Comparison of a β-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N. Engl. J. Med. 325:388-392.
9. Kraan, J., G. H. Koëter, T. W. van der Mark, H. J. Sluiter, and K. de Vries. 1985. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J. Allergy Clin. Immunol. 76:628-636.
10. Kerrebijn, K. F., E. E. M. van Essen-Zandvliet, and H. J. Neijens. 1987. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J. Allergy Clin. Immunol. 79:653-659.
11. Waalkens, H. J., J. Gerritsen, G. H. Koëter, F. H. Krouwels, W. M. C. van Aalderen, and K. Knol. 1991. Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow. Thorax 46:499-503.
12. van Essen-Zandvliet, E. E., M. D. Hughes, H. J. Waalkens, E. J. Duiverman, S. J. Pocock, K. F. Kerrebijn, and Dutch Chronic Non-specific Lung Disease Study Group. 1992. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am. Rev. Respir. Dis. 146:547-554.
13. de Jong, J. W., J. P. Teengs, D. S. Postma, T. W. van der Mark, G. H. Koëter, and J. G. R. de Monchy. 1994. Nedocromil sodium versus albuterol in the management of allergic asthma. Am. J. Respir. Crit. Care Med. 149:91-97.
14. van Schayck, C. P., S. J. Graafsma, M. B. Visch, E. Dompeling, C. van Weel, and C. L. A. Herwaarden. 1990. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J. Allergy Clin. Immunol. 86:793-800.
15. Cockcroft, D. W., C. P. McParland, S. A. Britto, V. A. Swystun, and B. C. Rutherford. 1993. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 342:833-837.
16. 2-agonists in asthma. N. Engl. J. Med. 327:1204-1208.
17. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N. Engl. J. Med. 327:1198-1203.
18. Vathenen, A. S., A. J. Knox, B. G. Higgins, J. R. Britton, and A. E. Tattersfield. 1988. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 332:554-558.
19. 2-agonist treatment. Am. Rev. Respir. Dis. 148:707-712.
20. Davis, A. O., and R. J. Lefkowitz. 1984. Regulation of beta-adrenergic receptors by steroid hormones. Annu. Rev. Physiol. 46:119-130.
21. 2-adrenoceptor gene expression in human lung (abstract). Am. Rev. Respir. Dis. 145:A834.
22. Quanjer, P. H. 1983. Standardized lung function testing. Bull. Eur. Physiopathol. Respir. 19(Suppl. 5):7-28.
23. Sterk, P. J., L. M. Fabbri, P. H. Quanjer, D. W. Cockcroft, P. M. O'Byrne, S. D. Anderson, E. F. Juniper, and J. L. Malo. 1993. Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur. Respir. J. 6(Suppl. 16):53-83.
24. SAS System for Windows 3.10, release 6.08, 1992. SAS Institute Inc., Cary, NC.
25. Kerstjens, H. A. M., P. L. P. Brand, M. D. Hughes, N. J. Robinson, D. S. Postma, H. J. Sluiter, E. R. Bleecker, P. N. R. Dekhuijzen, P. M. de Jong, H. J. J. Mengelers, S. E. Overbeek, D. F. M. E. Schoonbrood, and the Dutch Chronic Non-specific Lung Disease Study Group. 1992. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N. Engl. J. Med. 327:1413-1419.
26. Juniper, E. F., P. A. Kline, M. A. Vanzieleghem, E. H. Ramsdale, P. M. O'Byrne, and F. E. Hargreave. 1990. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am. Rev. Respir. Dis. 142:832-836.
27. Wong, C. S., I. Wahedna, I. D. Pavord, and A. E. Tattersfield. 1994. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge. Am. J. Respir. Crit. Care Med. 150:1268-1273.